Home

The Brenk Lab

Professor Ruth Brenk

The overall research goal of the Brenk lab is to improve methods used for structure-based drug design and to apply these methods to design inhibitors for enzymes with biological relevance. A key point in our research is the interplay of theoretical and experimental methods.

For more details, check out our research page.

New review article

Review about ligand design for riboswitches published

About state-of the art of riboswitch ligand design and future perspectives.

Webinar

Structure-based design of riboswitch and kinase ligands

A webinar about structure-based design of riboswitch and kinase ligands.

News

Millions to research for discovering new antibiotics

Ruth Brenk at The Department of biomedicine received a grant of 7 million NOK for research to discover new antibiotics. The work will be carried out with collaborators at the Indian Institute of Chemical Technology.

Research funding from NFR

Chartering chemical space of riboswitch ligands - towards future antibiotics

The Brenk lab will receive funding from NFR for developing future antibiotics acting via riboswitch binding. This project will fund two postdoc positions for three years, one in the lab of Bengt Erik Haug (Department of Chemistry) and one in the Brenk group. We are looking forward to continuing an...

News

Partner of Digital Life Norway

Our research about development of riboswitch ligands was chosen as partner project for Digital Life Norway.

We offer topics for the degree MSc in the area of structure-based drug design, e.g. molecular modelling, fragment screening and X-ray crystallography. Don't hestitate to contact us for chat to discuss what exactly we can offer and how we can tailor this to match your  interests.

The Brenk Lab is part of the Biorecognition Resarch Group.